1-2 of 2
Alessia Ripamonti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Results of Phase 2 Open Label Study of Lorlatinib Monotherapy in Relapsed/Refractory ALK + Lymphomas Previously Treated with Other Tyrosine Kinase Inhibitors

Alessia Ripamonti, Andrea Aroldi, Federica Cocito, Luca Guerra, Lavinia Monaco, Bianca Maria Granelli, Lara Mussolin, Carlo Gambacorti-Passerini
Journal: Blood
Blood (2023) 142 (Supplement 1): 4474.
https://doi.org/10.1182/blood-2023-186702
Published: 2023
Journal Articles

Neutrophil to Lymphocyte Ratio (NLR) at Diagnosis Is a Predictor of Venous Thrombosis and Poor Outcome in Patients with Prefibrotic Primary Myelofibrosis

Fabrizio Cavalca, Francesca Palandri, Novella Pugliese, Alessia Ripamonti, Ambra Di Veroli, Mattia Biondo, Carlo Gambacorti-Passerini, Roberto Latagliata, Elena Maria Elli
Journal: Blood
Blood (2022) 140 (Supplement 1): 9711–9712.
https://doi.org/10.1182/blood-2022-165456
Published: 2022